Global Surgical Site Infection (SSI) Epidemiology Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--()--The "Surgical Site Infection (SSI) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

This 'Surgical site infection (SSI)-Epidemiology Forecast - 2030' report delivers an in-depth understanding of the Surgical site infection (SSI), historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Surgical site infection (SSI) Epidemiology

The Surgical site infection (SSI) epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted surgical site infection (SSI) epidemiology segmented as the Total Surgical Procedures, Number of Surgical Procedures by Type, Total Incident cases of Surgical Site Infections (SSI) and Incidence of Surgical Site Infections (SSI) by Type.

The report includes the Incident scenario of Surgical site infection (SSI) symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country-wise Surgical site infection (SSI) Epidemiology

The epidemiology segment also provides the Surgical site infection (SSI) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The total Incident population of Surgical site infection (SSI) Associated in 7MM countries was estimated to be 1,275,912 cases in 2020 and expected to decline at a CAGR of ?5.11% for the study period, i.e., 2018-2030.

  • As per the estimates, the US has the highest Incident population of Surgical site infection (SSI)
  • Among the EU5 countries, UK had the highest Incident population of surgical site infection (SSI). On the other hand, Italy had the lowest number of cases, as 61,942 cases in 2020.

Scope of the Report

  • Surgical site infection (SSI) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
  • Surgical site infection (SSI) Epidemiology Report and Model provide an overview of the risk factors and global trends of Surgical site infection (SSI) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight into the historical and forecasted patient pool of Surgical site infection (SSI) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps recognize the growth opportunities in the 7MM concerning the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Surgical site infection (SSI)
  • The report provides the segmentation of the Surgical site infection (SSI) epidemiology by Incident Cases of Surgical site infection (SSI) in 7MM
  • The report provides the segmentation of the Surgical site infection (SSI) epidemiology by Type-specific Incident Cases of Surgical site infection (SSI) in 7MM

Report Highlights

  • 10-year Forecast of Surgical site infection (SSI) epidemiology
  • 7MM Coverage
  • Total Incident Cases of Surgical site infection (SSI)
  • Incident Cases according to segmentation: Type-specific Incidence of Surgical site infection (SSI)

KOL Views

The publisher interviews KOLs, and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM concerning the patient population about surgical site infection (SSI)?
  • What are the key findings of surgical site infection (SSI) epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2018-2030)?
  • What would be the total number of patients with surgical site infection (SSI) across the 7MM during the forecast period (2018-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2018-2030)?
  • At what CAGR the patient population is expected to grow by 7MM during the forecast period (2018-2030)?
  • What are the disease risk, burden, and unmet needs of surgical site infection (SSI)?
  • What are the currently available treatments for surgical site infection (SSI)?

Reasons to Buy

  • Develop business strategies by understanding the trends shaping and driving the global Surgical site infection (SSI) market
  • Quantify patient populations in the global Surgical site infection (SSI) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Surgical site infection (SSI) therapeutics in each of the markets covered
  • Understand the magnitude of Surgical site infection (SSI) population by its Incidence cases
  • Understand the magnitude of Surgical site infection (SSI) population by its Type-specific cases
  • The Surgical site infection (SSI) epidemiology report and model was written and developed by Masters and PhD level epidemiologists
  • The Surgical site infection (SSI) Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

For more information about this report visit https://www.researchandmarkets.com/r/jta24b

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900